Other Transactions

Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

Homepage
About Us
Services
News Feed
Contact
English
- English
- 中文

Other Transactions

May 26, 2023

No comments

About the author.

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent blog post.

Key Biopharma Deals of 2024

Posted: 7 hours ago
KYBORA Welcomes Stefan Bluemmers as Managing Director

Posted: 3 days ago
Accelerated Approval (AA) and PRV Grant: Implications of the FDA’s Updated Guidance

Posted: 1 week ago
Empowering Dreams through Foundation Rwanda’s KYBORA Program

Posted: 1 week ago
Navigating the Complexities of Priority Review Vouchers in the Context of Accelerated Approval Withdrawals

Posted: 4 weeks ago

Tags.

Tell us about your business and corporate development needs.

Contact Us

KYBORA is a global advisory firm whose mission is to guide transformative healthcare companies to enduring success globally, by offering optimal M&A, licensing, fundraising and strategic advisory services in all key markets around the world.

About Us.

About KYBORA
Meet our team
Success Story
Our Global Presence

Our Services.

M&A
Licensing
Fundraising
Strategic Advisory

Latest News Feed.

Key Biopharma Deals of 2024

Posted: 7 hours ago
KYBORA Welcomes Stefan Bluemmers as Managing Director

Posted: 3 days ago

Terms of service | Privacy policy

Other Transactions

About the author.

Drcom Content Editor

No Comments. Leave a comment

Leave a Reply

Recent blog post.

Key Biopharma Deals of 2024

KYBORA Welcomes Stefan Bluemmers as Managing Director

Accelerated Approval (AA) and PRV Grant: Implications of the FDA’s Updated Guidance

Empowering Dreams through Foundation Rwanda’s KYBORA Program

Navigating the Complexities of Priority Review Vouchers in the Context of Accelerated Approval Withdrawals

TYPE & ENTER: